Tumor-infiltrating lymphocytes improves PFS in metastatic melanoma
Tumor-infiltrating lymphocytes therapy has been shown to be more effective than ipilimumab in treating patients with advanced melanoma, making tumor-infiltrating lymphocytes a promising new treatment option.